IA
REVB icon

IFP Advisors’s Revelation Biosciences REVB Stock Holding History

IFP Advisors’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-354
Closed -$1.61K – 5005
2025
Q1 		$1.61K Buy
+354
New +$19.8K ﹤0.01% 3215

Other funds holding REVB

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

IFP Advisors's REVB Position: Q2 2025 in Review

IFP Advisors sold out of Revelation Biosciences (REVB) in Q2 2025, closing a stake of 354 shares — an estimated $1.61K sold.

IFP Advisors first reported a position in REVB in Q1 2025 and held it in 1 quarter. The position peaked at $1.61K in Q1 2025. 7 funds tracked by Wall St. Rank hold REVB as of Q2 2025.

  • IFP Advisors reported no remaining Revelation Biosciences position as of Q2 2025 after selling out during the quarter.
  • IFP Advisors sold 354 Revelation Biosciences shares in Q2 2025, an estimated $1.61K.
  • IFP Advisors first reported a position in Revelation Biosciences in Q1 2025 and held it in 1 quarter.
  • IFP Advisors's Revelation Biosciences position peaked at $1.61K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Revelation Biosciences as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.